Allogeneic hematopoietic stem cell transplantation from a 2-HLA-haplotype-mismatched family donor for posttransplant relapse: a prospective phase I/II study-Reference-Cited by-同舟云学术

Allogeneic hematopoietic stem cell transplantation from a 2-HLA-haplotype-mismatched family donor for posttransplant relapse: a prospective phase I/II study

Published:2020-06-20 Issue:1 Volume:56 Page:70-83
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Ikegame Kazuhiro^ORCID,Kaida Katsuji,Fukunaga Keiko,Osugi Yuko,Yoshihara Kyoko,Yoshihara Satoshi^ORCID,Ishii Shinichi,Fujino Satoshi,Yamashita Takaya,Mayumi Azusa,Maruyama Satoshi^ORCID,Teramoto Masahiro,Inoue Takayuki,Okada Masaya,Tamaki Hiroya^ORCID,Ogawa Hiroyasu,Fujimori Yosihiro

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/s41409-020-0980-8.pdf

Reference57 articles.

1. Eapen M, Giralt SA, Horowitz MM, Klein JP, Wagner JE, Zhang MJ, et al. Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant. Bone Marrow Transplant. 2004;34:721–7.

2. Lim ABM, Curley C, Fong CY, Bilmon I, Beligaswatte A, Purtill D, et al. Acute myeloid leukaemia relapsing after allogeneic haemopoietic stem cell transplantation: prognostic factors and impact of initial therapy of relapse. Intern Med J. 2018;48:276–85.

3. Choi EJ, Lee JH, Lee JH, Park HS, Ko SH, Seol M, et al. Treatment and clinical outcomes of patients relapsing after allogeneic hematopoietic cell transplantation for myelodysplastic syndrome. Blood Res. 2018;53:288–93.

4. Ruutu T, de Wreede LC, van Biezen A, Brand R, Mohty M, Dreger P, et al. Second allogeneic transplantation for relapse of malignant disease: retrospective analysis of outcome and predictive factors by the EBMT. Bone Marrow Transplant. 2015;50:1542–50.

5. Spitzer B, Perales MA, Kernan NA, Prockop SE, Zabor EC, Webb N, et al. Second allogeneic stem cell transplantation for acute leukemia using a chemotherapy-only cytoreduction with clofarabine, melphalan, and thiotepa. Biol Blood Marrow Transplant. 2016;22:1449–54.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Donor-derived cytomegalovirus-specific CD8+ T cells restricted to shared, donor-specific, or host-specific HLA after HLA mismatched hematopoietic stem cell transplantation;Transplant Immunology;2024-12

2. PLASMA EXCHANGE FOR TRANSPLANTATION-ASSOCIATED THROMBOTIC MICROANGIOPATHY IN STEM CELL TRANSPLANTATION FROM AN HLA-MISMATCHED FAMILY DONOR;Japanese Journal of Transfusion and Cell Therapy;2023-06-26

3. Successful outcomes of second hematopoietic stem cell transplantation for graft failure in pediatric patients with severe aplastic anemia;Scientific Reports;2022-06-22

4. Unmanipulated haploidentical stem cell transplantation using low-dose ATG and steroid for high-risk diseases;Journal of Hematopoietic Cell Transplantation;2020